Critical Appraisal of North African Medicinal Plant Activity Against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii
Journal of Medical Sciences · 25.10.2026 · 21 (3) · 5-19
DOI: 10.51984/qydhp576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Sciences, online erschienen am 25.10.2026. Verfasst von Sultana Mohamed Al-Aswad und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii cause hospital outbreaks across North Africa, where access to newer antibiotics is limited and plant-derived agents are widely proposed as alternatives. This critical narrative review appraises what the published evidence from Algeria, Egypt, Libya, Morocco and Tunisia can support. A scholarly index was searched on 9 October 2026, and complemented by a structured PubMed search; thirteen primary studies that tested plant-derived material against isolates documented as carbapenem-resistant or carbapenemase-positive were appraised, three of them in full text, across five domains: identity of the material, characterisation of the isolates, assay design, interpretation of potency and synergy, and translational depth. A minority of studies reported carbapenemase genes for the tested isolates, none of those read reported cytotoxicity, and stand-alone minimum inhibitory concentrations of oils and extracts generally exceeded conventional potency criteria. The strongest signal came from carvacrol- and thymol-rich oils of the mint family: in one Tunisian study carvacrol at 2–4 µg/mL lowered imipenem minimum inhibitory concentrations to the susceptible range in seven of twelve isolates, while five did not reach it. On a four-level evidence scale no candidate reached confirmatory readiness, one group reached the level of credible lead, and most other claims could not be falsified because the material or the isolates were undefined. The review proposes a minimum reporting standard and sets priorities: a shared set of genotyped isolates, authenticated and chemically defined material, reference-method testing adapted for volatile agents, selectivity and larval-model data, and tests against oxacillinase (OXA)-type carbapenemases.
Zitieren
APA
Al-Aswad, S. M., & Abobaker, A. M. (2026). Critical Appraisal of North African Medicinal Plant Activity Against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii. Journal of Medical Sciences, 21(3), 5-19. https://doi.org/10.51984/qydhp576
Vancouver
Al-Aswad SM, Abobaker AM. Critical Appraisal of North African Medicinal Plant Activity Against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii. Journal of Medical Sciences. 2026;21(3):5-19. doi:10.51984/qydhp576
BibTeX
@article{AlAswad2026,
author = {Al-Aswad, Sultana Mohamed and Abobaker, Abdelgani Mohammed},
title = {Critical Appraisal of North African Medicinal Plant Activity Against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii},
journal = {Journal of Medical Sciences},
year = {2026},
volume = {21},
number = {3},
pages = {5--19},
doi = {10.51984/qydhp576}
}
EUVIMED